NASDAQ Composite opens in less than five hours and Moderna’s premarket value is already 3.81% up.
The last session, nASDAQ Composite ended with Moderna rising 2.68% to $114.39. NASDAQ Composite dropped 0.38% to $12,850.22, following last session’s downward trend on what was a somewhat rough trend trading session.
Moderna’s last close was $111.40, 56.05% under its 52-week high of $178.50.
News about Moderna today
Moderna in talks with south korea to provide about 40 mln doses of Covid-19 vaccine. According to today’s article on Business Insider, "Moderna Inc. (MRNA) confirmed Tuesday that it is engaged in discussions with the government of South Korea to potentially provide 40 million or more doses of the Moderna COVID-19 Vaccine."
Moderna’s sales growth is 1841.7% for the ongoing quarter and 19117.5% for the next. The company’s growth estimates for the ongoing quarter is a negative 13.5% and positive 660% for the next.
Moderna’s last day, last week, and last month’s average volatility was a negative 10.76%, a negative 4.82%, and a positive 0.17%, respectively.
Moderna’s last day, last week, and last month’s high and low average amplitude percentage was 10.65%, 10.59%, and 10.66%, respectively.
Previous days news about Moderna
Moderna to offer vaccine to workers, contractors and board. According to The Wall Street Journal on Tue Dec 29, "The Cambridge, Mass., company, which has about 1,200 employees, said the small quantities of vaccine needed for the program are separate from the millions of doses Moderna has committed to the U.S. government.", "Moderna Inc. said Tuesday it will offer its new Covid-19 vaccine to its own employees, contractors and board members in a move the company said would provide an additional layer of protection to workers involved in making and delivering the vaccine."